Phathom Pharmaceuticals Announces Board and Executive Changes
Ticker: PHAT · Form: 8-K · Filed: Apr 16, 2025 · CIK: 1783183
| Field | Detail |
|---|---|
| Company | Phathom Pharmaceuticals, Inc. (PHAT) |
| Form Type | 8-K |
| Filed Date | Apr 16, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: management-change, executive-compensation, board-of-directors
TL;DR
Phathom Pharma shakes up board & exec pay. Big changes coming?
AI Summary
Phathom Pharmaceuticals, Inc. announced on April 11, 2025, changes in its board of directors and executive compensation arrangements. The filing details the departure of certain officers and directors, the election of new directors, and updates to compensatory arrangements for key personnel.
Why It Matters
Changes in leadership and executive compensation can signal shifts in company strategy, financial priorities, or operational focus, potentially impacting investor confidence and future performance.
Risk Assessment
Risk Level: medium — Board and executive changes can indicate internal restructuring or strategic shifts that may carry inherent risks.
Key Numbers
- 001-39094 — SEC File Number (Identifies the company's filing with the SEC)
- 82-4151574 — EIN (Employer Identification Number for tax purposes)
Key Players & Entities
- Phathom Pharmaceuticals, Inc. (company) — Registrant
- April 11, 2025 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of incorporation
- Florham Park, New Jersey (location) — Principal executive offices
FAQ
What specific roles have been affected by the departure of officers or directors?
The filing indicates the departure of 'certain officers' and 'directors' but does not specify the exact roles in this section.
Who are the newly elected directors?
The filing mentions the election of directors but does not list their names in the provided text.
What are the key changes in compensatory arrangements?
The filing notes updates to 'Compensatory Arrangements of Certain Officers' but does not detail the specific changes in the provided text.
What is the exact date of the earliest event reported?
The earliest event reported is dated April 11, 2025.
Where are Phathom Pharmaceuticals' principal executive offices located?
Phathom Pharmaceuticals' principal executive offices are located at 100 Campus Drive, Suite 102, Florham Park, New Jersey 07932.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on April 16, 2025 regarding Phathom Pharmaceuticals, Inc. (PHAT).